SCHEMBL22384157

SCHEMBL22384157

CC(C)(C)OC(=O)C(Cc1ccc(-c2ncc(C#N)cn2)cc1)NC(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ ROCK2 O75116 2/20 0.43
▸ XDH P47989 1/20 0.42
▸ CTSS P25774 2/20 0.41
▸ CTSK P43235 2/20 0.41
▸ CTSB P07858 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CTSG P08311 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CMA1 P23946 1/20 0.41
▸ PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15037131 1.00 EPHX2 (0.44) EPHX2MAPTTDP1POLBROCK2
SCHEMBL15091963 0.88 EPHX2 (0.47) EPHX2XDHCTSSCTSKCTSB
SCHEMBL15091968 0.88 EPHX2 (0.47) EPHX2XDHCTSSCTSKCTSB
SCHEMBL15037039 0.87 MAPT (0.46) MAPTTDP1POLBROCK2MEN1
SCHEMBL16295279 0.87 ROCK2 (0.49) EPHX2MAPTTDP1POLBROCK2
SCHEMBL16342898 0.87 MAPT (0.46) MAPTTDP1POLBROCK2MEN1
SCHEMBL16295278 0.87 ROCK2 (0.49) EPHX2MAPTTDP1POLBROCK2
SCHEMBL22384169 0.87 MAPT (0.45) MAPTTDP1POLBROCK2MEN1
SCHEMBL28294750 0.86 MAPT (0.50) MAPTTDP1POLBROCK2MEN1
SCHEMBL28294749 0.86 MAPT (0.50) MAPTTDP1POLBROCK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008056-B1 NOVEL GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-12-09 — — EP disclosed
EP-2791112-B1 CARBOXYLIC ACID DERIVATIVES COMPRISING FOUR CYCLES ACTING AS GLP-1 RECEPTOR MODULATORS FOR THERAPY OF DISEASES SUCH AS DIABETES CELGENE INT II SÀRL (CH) 2020-09-23 — — EP disclosed
EP-3230276-B1 GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-09-02 — — EP disclosed
CN-104080767-A Novel GLP-1 receptor modulators RECEPTOS INC 2014-10-01 — — CN disclosed
Send feedback